Home
Conditions
Small Cell Lung Carcinoma

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

835 public trials 210 recruiting studies

Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Recruiting

Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients

NCT07242547

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Hospital General Universitario de Albacete Albacete, Spain

Hospital General Universitario Dr. Balmis de Alicante Alicante, Spain

Hospital General Universitario de Elche Elche, Alicante, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View all 20 locations

View Trial Details

Recruiting

Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer

NCT07423585

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +8 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

NCT07358676

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations: Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

DLL3-Targeted PET/CT in Small Cell Lung Cancer

NCT07677787

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, DLL3-targeted PET/CT, +11 more
Locations: The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

NCT07149363

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: University of Illinois Chicago Chicago, Illinois, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

University of Virginia Comprehensive Cancer Center Charlottesville, Virginia, United States

View Trial Details

Recruiting

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

NCT06598306

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Cancer, +8 more
Locations: University of Southern California, Norris Comprehensive Cancer Center Los Angeles, California, United States

University of Illinois Chicago Chicago, Illinois, United States

Trinity Health Saint Joseph Mercy Ann Arbor Ann Arbor, Michigan, United States

Avera Cancer Institute Sioux Falls, South Dakota, United States

View all 31 locations

View Trial Details

Recruiting

A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)

NCT07652736

Conditions: Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: Hospital General de Segovia Segovia, Spain

View Trial Details

Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

NCT07046923

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +28 more
Locations: Stanford Medicine Cancer Center Stanford, California, United States

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute Orlando, Florida, United States

Florida Cancer Specialists - Sarasota Sarasota, Florida, United States

The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States

View all 27 locations

View Trial Details

Recruiting

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

NCT07508852

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease, +15 more
Locations: Peking university first hospital nuclear medicine Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer

NCT07153055

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations: Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

View Trial Details

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma trial results

Related conditions